Autopsy report · NCT01240304

A Phase II Study to Assess the Efficacy and Safety of Preoperative Chemo With Radiation Therapy for Patients With Borderline Unresectable Adenocarcinoma of the Pancreas

“no subjects enrolled”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 8 years 11 months before it stopped.
• 10 participants enrolled.
• Results were posted on the registry 2 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

University of Arkansas

Sponsor type

University, hospital or other

Conditions

Pancreatic Cancer

Interventions

Gemcitabine; Radiation therapy; pancreaticoduodenectomy

Participants

10

Sites

1

Countries

United States

Trials that died the same way

• Vancomycin Treatment in Recurrent PSC in Liver Transplant Patients
  “0 subjects enrolled” (88% match in meaning)
• Investigational Study of Oral Fish Oil in Treating Parenteral Nutrition Associated Liver Disease
  “no subjects recruited” (86% match in meaning)
• Divalproex Sodium in the Treatment of the Cutaneous Manifestations of Scleroderma
  “No subjects were enrolled.” (86% match in meaning)
• Pilot Study: Post-Recovery LibEration From Oxygen in Exacerbated COPD
  “No participants were enrolled” (81% match in meaning)
• Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Colorectal Cancer
  “No participants enrolled” (81% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.